A detailed history of Financial Strategies Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Financial Strategies Group, Inc. holds 3,891 shares of MRK stock, worth $489,682. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,891
Previous 4,049 3.9%
Holding current value
$489,682
Previous $441,000 16.33%
% of portfolio
0.14%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$113.24 - $131.95 $17,891 - $20,848
-158 Reduced 3.9%
3,891 $513,000
Q4 2023

Jan 30, 2024

SELL
$100.18 - $109.02 $42,476 - $46,224
-424 Reduced 9.48%
4,049 $441,000
Q3 2023

Oct 18, 2023

SELL
$102.95 - $114.33 $2,573 - $2,858
-25 Reduced 0.56%
4,473 $460,000
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $3,759 - $4,820
-43 Reduced 0.95%
4,498 $498,000
Q3 2022

Oct 26, 2022

BUY
$84.53 - $94.96 $7,100 - $7,976
84 Added 1.88%
4,541 $391,000
Q2 2022

Aug 08, 2022

SELL
$83.49 - $94.64 $3,924 - $4,448
-47 Reduced 1.04%
4,457 $406,000
Q1 2022

Apr 29, 2022

SELL
$73.51 - $82.4 $28,815 - $32,300
-392 Reduced 8.01%
4,504 $370,000
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $4,119 - $5,160
-57 Reduced 1.15%
4,896 $375,000
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $24,012 - $26,408
-335 Reduced 6.34%
4,953 $372,000
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $10,265 - $11,354
146 Added 2.84%
5,288 $411,000
Q1 2021

May 06, 2021

BUY
$68.86 - $81.11 $206 - $243
3 Added 0.06%
5,142 $396,000
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $135,788 - $150,697
1,892 Added 58.27%
5,139 $420,000
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $2,122 - $2,405
29 Added 0.9%
3,247 $269,000
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $249,652 - $281,703
3,218 New
3,218 $293,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Financial Strategies Group, Inc. Portfolio

Follow Financial Strategies Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Strategies Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Strategies Group, Inc. with notifications on news.